Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Getty: Pfizer Corporate Headquarters in New York City.

In the midst of deep public angst over the rising cost of prescription meds, drug giant Pfizer agreed to pay roughly $785 million to put an end to a federal probe into whether it overcharged Medicaid programs for Protonix, a heartburn medication.

Jack Craver


Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2019 ALM Media Properties, LLC. All Rights Reserved.